vs
AtriCure, Inc.（ATRC）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
AtriCure, Inc.的季度营收约是Resolute Holdings Management, Inc.的1.2倍（$140.5M vs $117.7M），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $18.4M）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
ATRC vs RHLD — 直观对比
营收规模更大
ATRC
是对方的1.2倍
$117.7M
自由现金流更多
RHLD
多$170.8M
$18.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.5M | $117.7M |
| 净利润 | — | $-1.7M |
| 毛利率 | 75.0% | 55.7% |
| 营业利润率 | 1.8% | 30.2% |
| 净利率 | — | -1.5% |
| 营收同比 | 13.1% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.04 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCRHLD
| Q4 25 | $140.5M | $117.7M | ||
| Q3 25 | $134.3M | $120.9M | ||
| Q2 25 | $136.1M | $119.6M | ||
| Q1 25 | $123.6M | $103.9M | ||
| Q4 24 | $124.3M | — | ||
| Q3 24 | $115.9M | — | ||
| Q2 24 | $116.3M | — | ||
| Q1 24 | $108.9M | — |
净利润ATRCRHLD
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $-267.0K | $-231.0K | ||
| Q2 25 | $-6.2M | $-611.0K | ||
| Q1 25 | $-6.7M | $-3.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-7.9M | — | ||
| Q2 24 | $-8.0M | — | ||
| Q1 24 | $-13.3M | — |
毛利率ATRCRHLD
| Q4 25 | 75.0% | 55.7% | ||
| Q3 25 | 75.5% | 59.0% | ||
| Q2 25 | 74.5% | 57.5% | ||
| Q1 25 | 74.9% | 52.5% | ||
| Q4 24 | 74.5% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 74.7% | — | ||
| Q1 24 | 74.7% | — |
营业利润率ATRCRHLD
| Q4 25 | 1.8% | 30.2% | ||
| Q3 25 | 0.2% | 34.3% | ||
| Q2 25 | -4.5% | 34.0% | ||
| Q1 25 | -4.8% | 24.7% | ||
| Q4 24 | -11.7% | — | ||
| Q3 24 | -6.4% | — | ||
| Q2 24 | -6.2% | — | ||
| Q1 24 | -10.0% | — |
净利率ATRCRHLD
| Q4 25 | — | -1.5% | ||
| Q3 25 | -0.2% | -0.2% | ||
| Q2 25 | -4.5% | -0.5% | ||
| Q1 25 | -5.5% | -3.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.8% | — | ||
| Q2 24 | -6.9% | — | ||
| Q1 24 | -12.2% | — |
每股收益（稀释后）ATRCRHLD
| Q4 25 | $0.04 | $-0.20 | ||
| Q3 25 | $-0.01 | $-0.03 | ||
| Q2 25 | $-0.13 | $-0.07 | ||
| Q1 25 | $-0.14 | $-0.39 | ||
| Q4 24 | $-0.33 | — | ||
| Q3 24 | $-0.17 | — | ||
| Q2 24 | $-0.17 | — | ||
| Q1 24 | $-0.28 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.4M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $491.9M | $6.5M |
| 总资产 | $654.2M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资ATRCRHLD
| Q4 25 | $167.4M | $205.5M | ||
| Q3 25 | $147.9M | $148.0M | ||
| Q2 25 | $117.8M | $99.9M | ||
| Q1 25 | $99.9M | $71.0M | ||
| Q4 24 | $122.7M | — | ||
| Q3 24 | $130.3M | — | ||
| Q2 24 | $114.0M | — | ||
| Q1 24 | $106.0M | — |
总债务ATRCRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | $61.9M | $173.4M | ||
| Q2 25 | $61.9M | $177.1M | ||
| Q1 25 | $61.9M | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.9M | — | ||
| Q2 24 | $61.9M | — | ||
| Q1 24 | $61.9M | — |
股东权益ATRCRHLD
| Q4 25 | $491.9M | $6.5M | ||
| Q3 25 | $476.5M | $10.8M | ||
| Q2 25 | $464.5M | $9.6M | ||
| Q1 25 | $454.6M | $8.9M | ||
| Q4 24 | $461.0M | — | ||
| Q3 24 | $465.0M | — | ||
| Q2 24 | $462.1M | — | ||
| Q1 24 | $456.3M | — |
总资产ATRCRHLD
| Q4 25 | $654.2M | $333.4M | ||
| Q3 25 | $635.4M | $293.2M | ||
| Q2 25 | $608.8M | $253.3M | ||
| Q1 25 | $591.6M | $214.3M | ||
| Q4 24 | $609.3M | — | ||
| Q3 24 | $615.1M | — | ||
| Q2 24 | $597.3M | — | ||
| Q1 24 | $591.6M | — |
负债/权益比ATRCRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | 0.13× | 16.01× | ||
| Q2 25 | 0.13× | 18.42× | ||
| Q1 25 | 0.14× | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $18.4M | $189.2M |
| 自由现金流率自由现金流/营收 | 13.1% | 160.8% |
| 资本支出强度资本支出/营收 | 1.1% | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $48.3M | $313.2M |
8季度趋势，按日历期对齐
经营现金流ATRCRHLD
| Q4 25 | $20.0M | $196.1M | ||
| Q3 25 | $26.7M | $59.6M | ||
| Q2 25 | $21.6M | $48.9M | ||
| Q1 25 | $-11.0M | $18.4M | ||
| Q4 24 | $5.8M | — | ||
| Q3 24 | $20.0M | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $-21.0M | — |
自由现金流ATRCRHLD
| Q4 25 | $18.4M | $189.2M | ||
| Q3 25 | $24.1M | $58.6M | ||
| Q2 25 | $19.0M | $47.5M | ||
| Q1 25 | $-13.2M | $17.8M | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $16.4M | — | ||
| Q2 24 | $5.0M | — | ||
| Q1 24 | $-23.8M | — |
自由现金流率ATRCRHLD
| Q4 25 | 13.1% | 160.8% | ||
| Q3 25 | 18.0% | 48.5% | ||
| Q2 25 | 13.9% | 39.7% | ||
| Q1 25 | -10.7% | 17.1% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 14.1% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | -21.9% | — |
资本支出强度ATRCRHLD
| Q4 25 | 1.1% | 5.8% | ||
| Q3 25 | 1.9% | 0.8% | ||
| Q2 25 | 2.0% | 1.2% | ||
| Q1 25 | 1.8% | 0.6% | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 3.1% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 2.5% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage Management | $45.5M | 32% |
| Openheart | $38.5M | 27% |
| Other | $26.2M | 19% |
| Pain Management | $22.6M | 16% |
| Minimally Invasive | $7.7M | 6% |
RHLD
暂无分部数据
